9-Bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one - CAS 1438383-89-1
Catalog: |
BB009677 |
Product Name: |
9-Bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one |
CAS: |
1438383-89-1 |
Synonyms: |
9-bromo-3-(2-bromo-1-oxoethyl)-5,9,10,11-tetrahydronaphtho[7,6-c][2]benzopyran-8-one; 9-bromo-3-(2-bromoacetyl)-5,9,10,11-tetrahydronaphtho[7,6-c]isochromen-8-one |
IUPAC Name: | 9-bromo-3-(2-bromoacetyl)-5,9,10,11-tetrahydronaphtho[7,6-c]isochromen-8-one |
Description: | 9-Bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one (CAS# 1438383-89-1) is an antiviral agent and Velpatasvir (V116000) intermediate. Velpatasvir is a NS5A inhibitor in patients with hepatitis C (HCV) infection. |
Molecular Weight: | 450.12 |
Molecular Formula: | C19H14Br2O3 |
Canonical SMILES: | C1CC2=C(C=C3C(=C2)C4=C(CO3)C=C(C=C4)C(=O)CBr)C(=O)C1Br |
InChI: | InChI=1S/C19H14Br2O3/c20-8-17(22)11-1-3-13-12(5-11)9-24-18-7-14-10(6-15(13)18)2-4-16(21)19(14)23/h1,3,5-7,16H,2,4,8-9H2 |
InChI Key: | NVSLOKHCHIFJDR-UHFFFAOYSA-N |
LogP: | 4.71600 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2018103239-A1 | Preparation method for velpatasvir intermediate and analogue thereof | 20161205 |
CN-108147972-B | Preparation method of vipatavir intermediate and analogue thereof | 20161205 |
US-2017320885-A1 | Process for the preparation of intermediates useful in the preparation of hepatitis c virus (hcv) inhibitors | 20160505 |
US-9957279-B2 | Process for the preparation of intermediates useful in the preparation of Hepatitis C virus (HCV) inhibitors | 20160505 |
WO-2017191546-A1 | Process for the preparation of intermediates useful in the preparation of hepatitis c virus (hcv) inhibitors | 20160505 |
Complexity: | 523 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 449.92892 |
Formal Charge: | 0 |
Heavy Atom Count: | 24 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 447.93097 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 43.4 Å2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 4.6 |
-
Catalog: BB027076
(±)-Diethyl trans-4-cyclohexene-1,2-dicarboxylate
Detail
-
Catalog: BB015442
(±)-8a-Methyl-3,4,8,8a-tetrahydro-1,6(2H,7H)-naphthalenedione
Detail
-
Catalog: BB010056
(±)-cis-Cyclopentane-1,2-dicarboxylic acid
Detail
-
Catalog: BB032683
(-)-Dipivaloyl-L-tartaric Acid
Detail
-
Catalog: BB032573
(-)-Carvone
Detail
-
Catalog: BB009173
(+/-)-trans-Oxirane-2,3-dicarboxylic acid
Detail
-
Catalog: BB021353
(+)-O,O'-Di-p-toluoyl-D-tartaric Acid
Detail
-
Catalog: BB036558
(+)-O,O'-Dibenzoyl-D-tartaric Acid Monohydrate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS